Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

FENNEC PHARMACEUTICALS INC. Director's Dealing 2019

Nov 14, 2019

35599_dirs_2019-11-14_2a5fbc11-1a7c-4d09-94d7-0d2f86e524cd.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: FENNEC PHARMACEUTICALS INC. (FENC)
CIK: 0001211583
Period of Report: 2019-11-13

Reporting Person: Cook Jodi A (Director)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2019-11-13 Stock Option (right to buy) $5.40 A 20000 Acquired 2029-11-13 Common Shares (20000) Direct

Footnotes

F1: On November 13, 2019, Jodi Cook was granted an incentive stock option to purchase 20,000 shares of the Issuer's common shares pursuant to the Issuer's Amended and Restated Stock Option Plan. 100% of the shares under this option were fully vested on the date of grant